Cryopreserved Immune Cells to the Rescue!

  When the Covid-19 pandemic upended daily lives, biomedical research across the globe felt the strain as pandemic-related shipping and manufacturing delays began leading to supply line shortages. As lockdowns were instituted, cell therapy starting material became particularly difficult to source because the COVID-19 pandemic posed risks to donors traveling to hospitals and clinics. With…

The Need for COVID-19 Patient Donor Material

COVID-19 research has been the subject of intense global focus ever since it became obvious that the disease was spreading rapidly despite early efforts to contain it. As the devastating impact of COVID-19 became more apparent, countries have raced to coordinate the scientific efforts and resources necessary to fight the disease. COVID-19 itself has hampered…